Back to search

Article

Methylation risk score in peripheral blood predictive of conversion from mild cognitive impairment to Alzheimer's Disease

2024-03-15

Abstract excerpt

Background Alzheimer’s disease (AD) is a neurodegenerative and heterogeneous disorder with complex etiology. Mild cognitive impairment (MCI) may represent an intermediate stage of AD, and the ability to identify MCI patients at greater risk of conversion to AD could guide personalized treatments. This study sought to develop a methylation risk score predictive of conversion from MCI to AD using publicly available...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9118ce5-99b1-5ac8-a3b6-c062e7c99bc5
DOI
10.12688/f1000research.140403.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Methylation risk score in peripheral blood predictive of conversion from mild cognitive impairment to Alzheimer's DiseaseDOI 10.12688/f1000research.140403.2
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive statusSemantic proximity
Association of peripheral blood DNA methylation level with Alzheimer’s disease progressionSemantic proximity
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive statusSemantic proximity
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.Semantic proximity
Blood‐based multivariate methylation risk score for cognitive impairment and dementiaSemantic proximity
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjectsSemantic proximity
Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjectsSemantic proximity
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.Semantic proximity
A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's diseaseSemantic proximity
Epigenetic genes are differentially methylated in the blood of persons with mild cognitive impairment and Alzheimer’s diseaseSemantic proximity
Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's diseaseSemantic proximity
Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer’s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.